GoodRx Holdings (GDRX) Cash & Equivalents Growth (3y) (2022 - 2026)

GoodRx Holdings (GDRX) Cash & Equivalents Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Veeva Systems 27.35 Bn 20.79 Bn 662.02 Mn 20.14%
2 BrightSpring Health Services 12.12 Bn 11.24 Bn 482.22 Mn -
3 Healthequity 7.42 Bn 7.15 Bn 256.31 Mn 5.55%
4 Hinge Health 4.95 Bn 4.64 Bn 154.23 Mn -
5 Doximity 3.80 Bn 3.05 Bn 125.97 Mn 11.52%
6 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 13.84%
7 Waystar Holding 3.65 Bn 3.49 Bn 268.04 Mn -
8 Privia Health 2.66 Bn 2.29 Bn 595.71 Mn 10.47%
9 Omnicell 1.90 Bn 1.73 Bn 140.36 Mn -19.91%
10 GoodRx Holdings 904.11 Mn 668.40 Mn 112.95 Mn -32.34%

Historic Data

Download Data
DateValue
Mar 31, 2026 -32.34%
Dec 31, 2025 -29.81%
Sep 30, 2025 -27.87%
Jun 30, 2025 -27.25%
Mar 31, 2025 -29.13%
Dec 31, 2024 -21.90%
Sep 30, 2024 -22.55%
Jun 30, 2024 -16.29%
Mar 31, 2024 -18.65%
Dec 31, 2023 -11.46%
Sep 30, 2023 -9.57%
Jun 30, 2023 81.89%
Mar 31, 2023 99.51%
Dec 31, 2022 207.46%
Sep 30, 2022 130.27%